Dividends & Buybacks ·
At its 2026 Annual Meeting of Stockholders on June 16, 2026, DocGo Inc. stockholders approved a reverse stock split at…
DCGODocGo Inc.
At its 2026 Annual Meeting of Stockholders on June 16, 2026, DocGo Inc. stockholders approved a reverse stock split at a ratio to be determined by the Board of Directors between 1-for-5 and 1-for-10. Stockholders elected Vina Leite and James M. Travers as Class II directors, approved executive compensation on an advisory basis, and ratified Urish Popeck & Co., LLC as the independent auditor. Proposals to amend the Charter regarding the waiver of corporate opportunities and the limitation of officer liability were not approved. DocGo Inc. provides healthcare services and logistics.